More than 65 million people in the U.S. are enrolled in Medicare, the federal health insurance program for adults at least 65 ...

Formerly known as Lou Gehrig’s disease, amyotrophic lateral sclerosis is now commonly referred ... People with later stage disease typically require additional nursing support as well.

Medicare enrollment requires a person to be a permanent United States resident for 5 years or more. Read on for more ...

The candidate in question is VY9323, an AAV gene therapy combining a highly potent pri-miRNA against superoxide dismutase 1 ...

Multiple sclerosis (MS) in its end stages involves disabling and life threatening effects. Several home adaptations and palliative care are available and can improve survival, mobility ...

A case of a 26-year-old woman with a history (from the age of 2) of numerous, symmetrical amelanotic macules on the inguinal region, pubis, knees, and backs of the hands was admitted to the ...

After raising questions surrounding dosing levels, the FDA has freed Amylyx’s early-stage amyotrophic lateral sclerosis (ALS) candidate from a clinical hold. When Amylyx had asked the FDA to ...

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

The initial report of a patient with visceral scleroderma without skin involvement was published in 1954, [1] and in 1962, the term "progressive systemic sclerosis sine scleroderma" was coined.